Lynda Charters

Investigators conducted a cohort study to determine if there is a correlation between intake of nitrate and AMD progression based on previous suggestions that low nitrate levels in the diet may put patients at risk of AMD progression.

The researchers reported that there was no significant difference in the AMD prevalence among the 3 study groups.

Survey participants were asked to enumerate the signs, symptoms, and complaints, the preoperative visual acuities; complications requiring removal or exchange; and secondary interventions.

Investigators test the efficacy of phentolamine alone and with low-dose pilocarpine.

According to one surgeon, the technique may reduce the need for biopsies.

Automated AI tool offers offline capability and hope for patients.

In this preliminary study, researchers found that renal function might affect the response to IVBI treatment in patients with DME.

Heavy silicone oil tamponade in secondary surgery for persistent full-thickness macular holes is a safe and efficient surgical method. Best-corrected visual acuity and minimum linear diameter before surgery may be indicators for anatomical success.

Survey of academic chairs and residency directors recognizes centers of excellence in Best Clinical Care, Best Residency, Best Research, and Best Overall Programs.

Spanish investigators found that local resection may offer better visual results and eye sparing without compromising local tumor control and survival.

The drug is expected to be available to eye care clinicians in the US during the second half of 2023.

The investigators explained that deficient ophthalmologic care is costly to patients, making the identification of groups not receiving adequate care of vital importance

According to researcher, the treatment offers improved retinal sensitivity, visual function, and mobility.

Ophthalmologist discusses the impact of getting older on patients diagnosed with the disease.

The ocular biomarkers studied showed poor to moderate accuracy for detecting the 2 disorders.

CXL has been proven effective to treat patients with corneal ectasias.

Receiving FDA orphan drug designation allows the company to proceed with plans to advance the development of BRM424, a novel, first-in-class, potential treatment for neurotrophic keratitis.

Despite the latest advances in anti-VEGF therapy, a small group of patients do not achieve improved vision. Ophthalmologists are looking for options.

According to physicians, patients who do not undergo second procedure are more likely to develop glaucoma.

According to investigators, the risk for the development of dry eye disease is greater in postmenopausal women compared with those who have not reached menopause as a result of hormonal dysregulation of the ocular secretory glands.

Investigators who are examining end-stage disease see significant visual recovery in 2 patients.

Investigators find a link with a postoperative prolonged steroid response.

Patients surveyed say the handheld tool proved to be comfortable and easy to use.

The procedures may result in temporary pressure spikes later than expected.

The therapy offers improved retinal sensitivity, visual function, as well as improvements in mobility.

Investigators who are examining end-stage disease see significant visual recovery in 2 patients.

The SBL-3 ClearView clinical study, an FDA investigational device exemption clinical trial conducted at 18 sites across the US, is a prospective, subject-masked, randomized, two-arm study.

Several intravitreally injected anti-VEGF drugs are currently undergoing investigation.

The regulatory process is building confidence that the product is good and can be used safely.